Sushan Luo Selected Research

Interferon Type I

5/2021

The role of innate immunity in myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sushan Luo Research Topics

Disease

13	Myasthenia Gravis 01/2022 - 01/2019
6	Muscular Diseases (Myopathy) 05/2019 - 05/2014
2	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2022 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Myotonia 05/2020 - 01/2018
2	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 05/2020 - 01/2018
2	Channelopathies 05/2020 - 01/2018
2	Muscular Dystrophies (Muscular Dystrophy) 05/2019 - 11/2014
2	Paralysis (Palsy) 05/2019 - 01/2018
2	Leukoencephalopathies 05/2019 - 04/2019
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2019 - 11/2014
2	Distal Myopathies (Distal Muscular Dystrophy) 01/2019 - 01/2019
1	Rhabdomyosarcoma 01/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Dysferlinopathy 12/2021
1	Virus Diseases (Viral Diseases) 05/2021
1	Oculopharyngodistal Myopathy 01/2021
1	Disease Progression 01/2021
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 06/2020
1	Quadriplegia (Spastic Quadriplegia) 05/2019
1	Cognitive Dysfunction 05/2019
1	Microcephaly 04/2019
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 04/2019
1	Vision Disorders (Hemeralopia) 04/2019
1	Nonsyndromic Deafness 04/2019
1	Thymoma (Thymic Carcinoma) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Hyperkalemic Periodic Paralysis 01/2018
1	Hereditary Myopathy with Early Respiratory Failure 02/2015
1	Miyoshi myopathy 11/2014
1	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 05/2014

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2019
3	muskIBA 01/2022 - 06/2020
3	AutoantibodiesIBA 01/2022 - 01/2021
3	AntibodiesIBA 01/2022 - 12/2020
2	Serum AlbuminIBA 01/2022 - 01/2019
2	glucose-mannose-glucoseIBA 01/2021 - 01/2020
2	Cholinergic ReceptorsIBA 12/2020 - 11/2020
2	DysferlinIBA 01/2019 - 11/2014
1	Immunoglobulin G (IgG)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Complement Inactivating AgentsIBA 01/2022
1	BerberineIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Interferon Type IIBA 05/2021
1	CytokinesIBA 05/2021
1	ChemokinesIBA 05/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	5' Untranslated Regions (5' UTR)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 11/2020
1	ChloridesIBA 05/2020
1	SodiumIBA 05/2020
1	Ion Channels (Ion Channel)IBA 05/2019
1	PotassiumIBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 05/2019
1	Lysine-tRNA LigaseIBA 04/2019
1	Uridine Diphosphate (UDP)IBA 01/2019
1	N-acylmannosamine kinaseIBA 01/2019
1	AcetylglucosamineIBA 01/2019
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019
1	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2019
1	EnzymesIBA 01/2019
1	Voltage-Gated Sodium ChannelsIBA 01/2018
1	GlycogenIBA 10/2015
1	polyglucosanIBA 10/2015
1	glycogeninIBA 10/2015
1	Adenosine Triphosphatases (ATPase)IBA 10/2015
1	ConnectinIBA 02/2015
1	N- (7- dimethylamino- 4- methylcoumarinyl)maleimide (DACM)IBA 11/2014
1	LipidsIBA 05/2014

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2021
1	Aftercare (After-Treatment) 01/2021
1	Activities of Daily Living (ADL) 01/2021
1	Immunotherapy 01/2021